Precision Meets Compassion In Holistic Care
Ibogaine Treatment
Our Comprehensive Ibogaine Treatments are all medically
supervised by our experienced clinical staff. Our stabilization medications allow for pain free pre-treatment preparation and transition. Our protocols and procedures are combined with a holistic approach for high success rates.
We take the privacy and confidentiality of our clients very seriously. Every interaction is handled with the utmost care and discretion to ensure that sensitive information remains secure. We are committed to protecting your personal details and maintaining your trust at all times."
"In order to respect our clients' wishes and protect their privacy, we rarely post pictures of our clients. We understand that most clients prefer to keep their personal information and images private, and we honor that decision fully."
Treatment Options
* 5 Day Comprehensive Treatment
* 7 Day Comprehensive Treatment
* 10 Day Alcohol Detox and Treatment
* 12 Day Fentanyl Treatment
***************
All treatments are done in a clinical residential setting with physician and nursing supervision. All clients go through a comprehensive pre-screening process before admission.
***************
Integration coaching and counseling are implemented with all of our treatments.
At Oceanside Treatment Center, we our proud to conduct our own in-house clinical research on Ibogaine treatment with our clients. By tracking outcomes and recovery progress firsthand, we are able to contribute valuable insights to the field while ensuring that our methods remain innovative, effective, and patient centered
********************************************
Why choose Ibogaine
How Ibogaine works on the brain
Ibogaine treatment works by influencing neuroplasticity, which is the brain's ability to reorganize itself by forming new neural connections. When a person undergoes Ibogaine treatment, the compound interacts with receptors in the brain, particularly those involved in addiction and emotional regulation. This process helps "reset" neural pathways associated with cravings and destructive behavior. As a result, Ibogaine can help disrupt addictive patterns, allowing the brain to form new, healthier habits. By promoting neuroplasticity, Ibogaine facilitates changes in thinking patterns, reduces compulsive cravings, and supports the development of healthier coping mechanisms, ultimately aiding in breaking the cycle of addiction and fostering long-term recovery.
Client testimonial
Eric M
I went to Oceanside Ibogaine Treatment Center 2 years ago and today I'm sober. I was drinking heavily daily and it was just a horrible cycle. I'm 55 years old and I knew I was in trouble if I didn't get help. I went through 2 in patient traditional treatment centers in the past but I always relapsed soon after. I read up that Ibogaine will reset pathways and help change that desire for my brain to want alcohol. I needed something big. I went through a five day medical detox before my treatment. I had my liver and all my blood work checked and an ekg prior to treatment. I started on vitamins, magnesium, and electrolytes before treatment. The staff and the whole team is amazing. I'm so grateful for the care I received at Oceanside Treatment Center Bahamas. I referred two other friends to them and they all did very well and were happy with the center. I would highly recommend Oceanside Ibogaine Clinic to anyone who wants to get sober. I can't thank you enough.
Oceanside in-house research study on methamphetamine use
Clinical research study on methamphetamine use with positive outcomes
Oceanside Treatment Center Nassau, Bahamas
A Prospective Longitudinal Observational Study on Clinical Ibogaine Treatment for Methamphetamine Use Disorder
1. Introduction
Methamphetamine use disorder is a significant and escalating public health challenge due to the drug's high potential for addiction and neurotoxicity. In response to the need for more effective treatment strategies, this study was conducted at Oceanside Treatment Center in Nassau, Bahamas, to evaluate the outcomes of Clinical Ibogaine Treatment in individuals with methamphetamine dependence. The primary goal was to assess abstinence at 3, 6, and 12 months post-treatment among clients who completed the full protocol and engaged in structured aftercare.
2. Study Design
Study Type: Prospective Longitudinal Observational Study
Location: Oceanside Treatment Center, Nassau, Bahamas
Study Duration: 12 months (March 24, 2023 - March 22, 2024)
Sample Size: 24 clients
Inclusion Criteria:
- Diagnosed with methamphetamine use disorder
- Daily use of methamphetamine between 0.5g and 2g
- Duration of use from 1 to 6 years
- Adults aged 18 and over
3. Participant Demographics
Total Participants: 24
Gender Breakdown:
- Male: 14 (58.3%)
- Female: 6 (41.7%)
Use History:
- Daily methamphetamine use ranged from 0.5 grams to 2 grams
- Duration of abuse ranged from 1 to 6 years
4. Treatment Protocol
Participants completed a 8-day inpatient treatment protocol consisting of the following components:
Days 1-5 (Pre-treatment Transition Phase):
- Medical assessment and stabilization
- Nutritional support and detox preparation
- Psychosocial counseling and integration
Day 6 (Ibogaine Administration):
- Clinical Ibogaine dose administered under full-time medical supervision
Days 7-8 (Post-treatment Monitoring):
- Observation, rest, and discharge planning
5. Aftercare Program
Following treatment, all clients participated in a structured aftercare counseling program, designed to reinforce the therapeutic effects of Ibogaine and support long-term abstinence.
Months 1-6: Two counseling sessions per week
Months 7-12: One counseling session per week
Participation Rate: 60% of participants engaged consistently in aftercare throughout the 12-month follow-up period
6. Outcome Measures
Primary Outcome: Abstinence from methamphetamine use at 3, 6, and 12 months post-treatment.
Time Point | Clients Abstinent | Percentage (n = 24)
-------------- |-------------------|---------------------
3 Months | 22 | 92%
6 Months | 20 | 83%
12 Months | 18 | 75%
Abstinence was determined through self-reporting, clinical observation, and follow-up assessments conducted during aftercare.
7. Observations
- Participants demonstrated a strong initial response to Ibogaine therapy, with a 92% abstinence rate at 3 months.
- Sustained abstinence at 6 months (83%) and 12 months (75%) indicates promising long-term efficacy.
- Continued engagement in counseling and support services appeared to positively influence recovery outcomes.
- The structured 8-day program, combined with consistent follow-up care, provided a comprehensive and effective framework for recovery from methamphetamine use disorder.
8. Conclusion
This prospective observational study provides evidence that Clinical Ibogaine Treatment, when delivered in a medically supervised and structured environment, can result in high rates of abstinence from methamphetamine use. The integration of aftercare support played a critical role in sustaining recovery, with strong outcomes observed at 3, 6, and 12 months post-treatment.
• 3 Months: 22 of 24 clients abstinent (92%)
• 6 Months: 20 of 24 clients abstinent (83%)
• 12 Months: 18 of 24 clients abstinent (75%)
Paradise Island Beach
Clients going for refreshing swim
Client relaxing at beach
The Power of Ibogaine Treatment
Oceanside beach at the yoga retreat
